Rick Muni

Sr Clinical Trial Manager at Worldwide Clinical Trials

Rick Muni is an experienced professional in the field of clinical research and trial management, currently serving as a Senior Clinical Trial Manager at Worldwide Clinical Trials since January 2023. Prior to this role, Rick held various positions at Labcorp Drug Development, including Project Manager in Clinical Pharmacology from May 2018 to January 2023. Additional experience includes serving as a Senior Clinical Research Associate at ICON plc from June 2016 to May 2018, and similar roles at PRA Health Sciences, INC Research, and Quintiles. Rick began the clinical research career as a Clinical Trials Assistant Intern at UNC Wilmington. Educational qualifications include a Bachelor of Science in Medical Research and a Master of Science in Pharmaceutical Development from the University of North Carolina at Wilmington.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Worldwide Clinical Trials

11 followers

About Worldwide Clinical Trials  Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.